Biological Lattice Industries, a Boston, MA-based company which specializes in biofabrication and life sciences R&D, raised $1.8M in Pre-Seed funding.
The round was led by Greek venture capital firm Uni.Fund.
The company intends to use the funds to expand operations and its business reach.
Led by Filippos Tourlomousis, Founder and CEO, Biological Lattice Industries Corp. (BLI) is a venture-backed startup founded in 2021 with the goal of democratizing biofabrication for life sciences R&D.
In conjunction with this funding announcement , BLI is introducing its solution for biofabrication: BioLoom™, its advanced multi-tool 3D bioprinter and Loominus Studio™, its unified software platform for biofabrication workflows.
FinSMEs
20/10/2024